HWA
SGMO

HHM Wealth Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

HHM Wealth Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50
Closed – – 735
2022
Q3 		$0 Hold
50
– – ﹤0.01% 780
2022
Q2 		$0 Hold
50
– – ﹤0.01% 836
2022
Q1 		$0 Hold
50
– – ﹤0.01% 744
2021
Q4 		$0 Hold
50
– – ﹤0.01% 700
2021
Q3 		$0 Hold
50
– – ﹤0.01% 655
2021
Q2 		$1K Hold
50
– – ﹤0.01% 601
2021
Q1 		$1K Hold
50
– – ﹤0.01% 569
2020
Q4 		$1K Hold
50
– – ﹤0.01% 516
2020
Q3 		$0 Hold
50
– – ﹤0.01% 536
2020
Q2 		$0 Hold
50
– – ﹤0.01% 525
2020
Q1 		$0 Buy
+50
New +$371 ﹤0.01% 469

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HHM Wealth Advisors's SGMO Position: Q4 2022 in Review

HHM Wealth Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2022, closing a stake of 50 shares.

HHM Wealth Advisors first reported a position in SGMO in Q1 2020 and held it in 11 quarters. The position peaked at $1K in Q2 2021. 182 funds tracked by Wall St. Rank hold SGMO as of Q4 2022.

  • HHM Wealth Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2022 after selling out during the quarter.
  • HHM Wealth Advisors sold 50 SANGAMO THERAPEUTICS INC shares in Q4 2022.
  • HHM Wealth Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q1 2020 and held it in 11 quarters.
  • HHM Wealth Advisors's SANGAMO THERAPEUTICS INC position peaked at $1K in Q2 2021.
  • 182 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2022.

Based on HHM Wealth Advisors's 13F filing for Q4 2022, filed 19 Jan 2023.